Baicalein and wogonin are activators of rat TREK-2 two-pore domain K+ channel

Acta Physiologica

Volumn 202, Issue 2, 2011, Pages 185-192

  Kim, E J ^a   Kang, D ^a   Han, J ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

Flavonoids; Neuroprotective agents; Potassium channels; Riluzole

Indexed keywords

BAICALEIN; FLAVONOID; POTASSIUM CHANNEL; RILUZOLE; TREK 1 PROTEIN; TREK 2 PROTEIN; UNCLASSIFIED DRUG; WOGONIN;

ANIMAL TISSUE; ARTICLE; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GENETIC TRANSFECTION; NEUROPROTECTION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; SCUTELLARIA BAICALENSIS;

ANIMALS; ANTIOXIDANTS; CERCOPITHECUS AETHIOPS; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; MEMBRANE POTENTIALS; NEUROPROTECTIVE AGENTS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; RATS; RILUZOLE;

EID: 79955658804     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2011.02263.x     Document Type: Article

References (47)

1. Akhlaghi, M. & Bandy, B. 2009. Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 46, 309-317.
2. + channel involved in polymodal pain perception. EMBO J 25, 2368-2376.
3. Atlante, A., Bobba, A., Paventi, G., Pizzuto, R. & Passarella, S. 2010. Genistein and daidzein prevent low potassium-dependent apoptosis of cerebellar granule cells. Biochem Pharmacol 79, 758-767.
4. + channel family. J Biol Chem 275, 17412-17419.
5. Bausch, A.R. & Roy, G. 1996. Volume-sensitive chloride channels blocked by neuroprotective drugs in human glial cells (U-138MG). Glia 18, 73-77.
6. Benavente-Garcia, O. & Castillo, J. 2008. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 56, 6185-6205.
7. + channels. EMBO J 22, 5403-5411.
8. Cheng, Y., He, G., Mu, X., Zhang, T., Li, X., Hu, J., Xu, B. & Du, G. 2008. Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile. Neurosci Lett 441, 16-20.
9. Cho, J. & Lee, H.K. 2004a. Wogonin inhibits excitotoxic and oxidative neuronal damage in primary cultured rat cortical cells. Eur J Pharmacol 485, 105-110.
10. Cho, J. & Lee, H.K. 2004b. Wogonin inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Biol Pharm Bull 27, 1561-1564.
11. Chou, T.C., Chang, L.P., Li, C.Y., Wong, C.S. & Yang, S.P. 2003. The antiinflammatory and analgesic effects of baicalin in carrageenan-evoked thermal hyperalgesia. Anesth Analg 97, 1724-1729.
12. Dajas, F., Rivera-Megret, F., Blasina, F., Arredondo, F., Abin-Carriquiry, J.A., Costa, G., Echeverry, C., Lafon, L., Heizen, H., Ferreira, M. & Morquio, A. 2003. Neuroprotection by flavonoids. Braz J Med Biol Res 36, 1613-1620.
13. Danesh-Meyer, H.V. & Levin, L.A. 2009. Neuroprotection: extrapolating from neurologic diseases to the eye. Am J Ophthalmol 148, 186-191. e182.
14. Debono, M.W., Le Guern, J., Canton, T., Doble, A. & Pradier, L. 1993. Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur J Pharmacol 235, 283-289.
15. Doble, A. 1996. The pharmacology and mechanism of action of riluzole. Neurology 47, S233-241.
16. (+) channels TREK-1 and TRAAK. Mol Pharmacol 57, 906-912.
17. Ettaiche, M., Fillacier, K., Widmann, C., Heurteaux, C. & Lazdunski, M. 1999. Riluzole improves functional recovery after ischemia in the rat retina. Invest Ophthalmol Vis Sci 40, 729-736.
18. Feng, J., Xu, W., Tao, X., Wei, H., Cai, F., Jiang, B. & Chen, W. 2010. Simultaneous determination of baicalin, baicalein, wogonin, berberine, palmatine and jatrorrhizine in rat plasma by liquid chromatography-tandem mass spectrometry and application in pharmacokinetic studies after oral administration of traditional Chinese medicinal preparations containing scutellaria-coptis herb couple. J Pharm Biomed Anal 53, 591-598.
19. Gao, Z., Huang, K., Yang, X. & Xu, H. 1999. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochim Biophys Acta 1472, 643-650.
20. Gao, Z., Huang, K. & Xu, H. 2001. Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. Pharmacol Res 43, 173-178.
21. + channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 65, 443-452.
22. + channel involved in neuroprotection and general anesthesia. EMBO J 23, 2684-2695.
23. Heurteaux, C., Laigle, C., Blondeau, N., Jarretou, G. & Lazdunski, M. 2006. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 137, 241-251.
24. (+) channel TREK-1. EMBO J 21, 2968-2976.
25. Kaneko, T., Chiba, H., Horie, N., Kato, T., Kobayashi, M., Hashimoto, K., Kusama, K. & Sakagami, H. 2010. Inhibition of prostaglandin E2 production by flavone and its related compounds. In Vivo 24, 55-58.
26. + channels. Trends Pharmacol Sci 24, 648-654.
27. Kim, Y., Lee, S.H. & Ho, W.K. 2007. Hydrogen peroxide selectively increases TREK-2 currents via myosin light chain kinases. Front Biosci 12, 1642-1650.
28. (+) currents in rat dorsal root ganglion neurons. Eur J Pharmacol 604, 20-26.
29. 2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro. Eur J Neurosci 27, 2501-2514.
30. Lang-Lazdunski, L., Heurteaux, C., Vaillant, N., Widmann, C. & Lazdunski, M. 1999. Riluzole prevents ischemic spinal cord injury caused by aortic crossclamping. J Thorac Cardiovasc Surg 117, 881-889.
31. Lee, H., Kim, Y.O., Kim, H., Kim, S.Y., Noh, H.S., Kang, S.S., Cho, G.J., Choi, W.S. & Suk, K. 2003a. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 17, 1943-1944.
32. Lee, H.H., Yang, L.L., Wang, C.C., Hu, S.Y., Chang, S.F. & Lee, Y.H. 2003b. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death. Brain Res 986, 103-113.
33. + channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors. J Biol Chem 275, 28398-28405.
34. Li, Z.B. & Wang, X.L. 2006. Recent advances in the study of arachidonic acid-sensitive and mechano-gated tandem-pore-domain potassium channels - TREK. Yao Xue Xue Bao 41, 193-196.
35. Li, Z.B., Zhang, H.X., Li, L.L. & Wang, X.L. 2005. Enhanced expressions of arachidonic acid-sensitive tandem-pore domain potassium channels in rat experimental acute cerebral ischemia. Biochem Biophys Res Commun 327, 1163-1169.
36. (+) channels TREK-1 and TRAAK. J Biol Chem 275, 10128-10133.
37. Mathie, A. & Veale, E.L. 2007. Therapeutic potential of neuronal two-pore domain potassium-channel modulators. Curr Opin Investig Drugs 8, 555-562.
38. Mottet, I., Demeure, R., Rataud, J., Lucas, M., Wahl, F., Warscotte, V., Thiran, J.P., Goudemant, J.F., Maldague, B., Maloteaux, J.M. & Stutzmann, J.M. 1997. Effects of riluzole on the evolution of focal cerebral ischemia: a magnetic resonance imaging study. MAGMA 5, 185-191.
39. Mu, X., He, G., Cheng, Y., Li, X., Xu, B. & Du, G. 2009. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental Parkinsonism in vivo and in vitro. Pharmacol Biochem Behav 92, 642-648.
40. (+) channels. Curr Opin Cell Biol 13, 422-428.
41. Schaffer, S., Schmitt-Schillig, S., Muller, W.E. & Eckert, G.P. 2005. Antioxidant properties of Mediterranean food plant extracts: geographical differences. J Physiol Pharmacol 56(Suppl 1), 115-124.
42. Schmitt-Schillig, S., Schaffer, S., Weber, C.C., Eckert, G.P. & Muller, W.E. 2005. Flavonoids and the aging brain. J Physiol Pharmacol 56(Suppl 1), 23-36.
43. Son, D., Lee, P., Lee, J., Kim, H. & Kim, S.Y. 2004. Neuroprotective effect of wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation. Eur J Pharmacol 493, 99-102.
44. Soory, M. 2009. Relevance of nutritional antioxidants in metabolic syndrome, ageing and cancer: potential for therapeutic targeting. Infect Disord Drug Targets 9, 400-414.
45. Tai, M.C., Tsang, S.Y., Chang, L.Y. & Xue, H. 2005. Therapeutic potential of wogonin: a naturally occurring flavonoid. CNS Drug Rev 11, 141-150.
46. Xu, X., Pan, Y. & Wang, X. 2004. Alterations in the expression of lipid and mechano-gated two-pore domain potassium channel genes in rat brain following chronic cerebral ischemia. Brain Res Mol Brain Res 120, 205-209.
47. Yang, L., Ma, J.H., Zhang, P.H., Zou, A.R. & Tu, D.N. 2009. Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment. Clin Exp Pharmacol Physiol 36, 154-161.